trial summary · NCT07862647
TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma
A Phase 1 Clinical Trial Evaluating the Safety and Tolerability of Bilateral Hemispheric 5-ALA-Mediated Sonodynamic Therapy Using the LIDU System Before Standard Radiochemotherapy and During Adjuvant Temozolomide in Patients With Histologically Proven Newly Diagnosed Butterfly Glioma
Trial record from the TrialBase DB dataset, status RECRUITING, condition Glioblastom WHO Grade 4, sponsored by Alpheus Medical, Inc.. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
This study is assessing the safety and tolerability of 5-ALA- mediated Porphyrin Metabolite Activation (PoMA) with LIDU ultrasound, in patients who have just been diagnosed with bihemispheric (in both sides of the brain) glioblastoma, sometimes called butterfly glioblastoma, before they complete their standard of care chemotherapy and radiation and after their standard of care chemotherapy and radiation while they are receviing their standard of care adjuvant chemotherapy.
Source record: https://clinicaltrials.gov/study/NCT07862647
Facts
| registry id | NCT07862647 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | Glioblastom WHO Grade 4 |
| sponsor | Alpheus Medical, Inc. |
| sponsor class | INDUSTRY |
| enrollment | 30 |
| start date | 2026-10-29 |
| primary completion | 2027-10-30 |
| completion | 2028-03-30 |
| results posted | not reported |
Conditions
- Glioblastom WHO Grade 4
- GBM
- bGBM
- Butterfly GBM
- Bihemispheric GBM
- Glioblastoma
Interventions
- 5-ALA
- Porphyrin Metabolite Activation (PoMA) with LIDU ultrasound
Countries
- United States
Intervention types: DEVICE, DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.